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Abstrad
The present work has studied mechanisms responsible
for indudion of early growth response 1 (EGR-1) gene
expression during monocytic differentiation of U-937
myeloid leukemia cells. Differentiation of U-937
cells with 1 2-O-tetradecanoylphorbol-1 3-acetate (IrA),
an adivator of the serine/threonine protein kinase C,
was associated with transcriptional adivation of EGR-1
promoter-reporter construds. The EGR-1 promoter
contains six CC(A/T)6GG (CArG) motifs. The two
5’-most distal CArG sequences conferred TPA
inducibility. In contrast, there was little effed of TPA on
EGR-1 transcription in a TPA-resistant U-937 cell
variant, designated TUR. Treatment of both U-937 and
TUR cells with okadaic acid, an inhibitor of serine/
threonine protein phosphatases 1 and 2A, was associated
with indudion of monocytic differentiation and EGR-1
transcription through the 5’-most CArG element.
Since these findings supported the involvement of
serine/threonine protein phosphorylation in the
regulation of EGR-1 expression, we studied adivation of
the 405 ribosomal protein 56 serine/threonine kinases,
pp7O￿ and pp9O￿. Although both kinases participate
in regulating cell growth, there was no detedable
adivation of pp7O￿ during TPA- or okadaic
acid-induced monocytic differentiation. Moreover,
rapamycin, an inhibitor of pp7O￿ adivation, had no
effed on indudion of EGR-1 expression. In contrast,
analysis of pp9O￿ adivity by phosphorylation of a
peptide derived from 56 protein demonstrated
stimulation of this kinase in TPA-treated U-937, and not
TUR, cells. Okadaic acid treatment of both cell types
was associated with adivation of pp9O￿. Since serum
response factor interacts with CArG elements and is
diredly phosphorylated by pp9O￿, the present findings
suggest that adivation of the pp9O￿’ cascade may
contribute to indudion of EGR-1 transcription and
appearance of the differentiated monocytic phenotype.
lntrodudion
Previous work has demonstrated that treatment of human
myeloid leukemia cell lines with TPA3 is associated with
induction of differentiation along the monocytic lineage
(1-3). TPA activates the serine/threonine-specific PKC (4),
and thus certain insights are available regarding early signals
in this process. Other studies have demonstrated that TPA-
induced differentiation of U-937 leukemia cells is accom-
panied by increased expression ofthe early growth response
1 (EGR-l , zif/268, NGF-IA, Krox24, TlS-8) gene (5-1 0). The
finding that this gene is activated by other agents which in-
duce monocytic differentiation of both leukemic cells and
normal monocytes suggested that EGR-l may function in
transducing early nuclear signals into longer term changes
in gene expression associated with the monocytic pheno-
type (1 1-1 3). Indeed, recent studies have suggested that
EGR-l is required for differentiation along the monocytic
lineage (1 4). EGR-l expression, however, is not restricted to
myeloid cells. Neuronal differentiation of PCi 2 rat pheo-
chromocytoma cells by nerve growth factor and cardiac dif-
ferentiation of the pluripotent embryonal carcinoma
P19518O1A1 line are associated with increases in EGR-l
transcripts (1 0). Moreover, the EGR-l gene is induced during
mitogenic stimulation of diverse cell types, including fibro-
blasts, epithelial cells, and lymphocytes (1 5, 16). Although
these findings have indicated that EGR-1 is involved in both
growth and differentiation, few insights are available regard-
ing the signaling mechanisms responsible for induction of
this gene.
Recent attention has been directed toward defining cy-
toplasmic and nuclear signaling pathways that contribute to
the regulation of immediate-early genes. This effort has in
part been focused on MAP kinases. Several serine/threonine
protein kinases have been implicated in the control of early
response gene expression on the basis of their spatial dis-
tribution and temporal regulation. These include the 405
ribosomal protein S6 kinases, designated pp9O￿￿ and
pp7oSbK (1 7-20). Activation of both pp9O￿’ and pp7#{216}SbK
involves serine/threonine phosphorylation but occurs
through distinct signaling pathways (1 8, 20-22). Although
the kinases responsible for activation of pp7OS6K remain un-
known, the MAP kinases pp44/42maPk/erk appear to regulate
pp9O￿’ activity (23, 24). Activated MAP kinases have been
shown to phosphorylate transcription factors such as Jun and
Fos in vitro (25, 26). Moreover, regulation of nuclear MAP
kinase and pp9orsk activities by growth factors is coordi-
nated with induction of certain early response genes (27).
These findings have suggested that MAP kinases and pp9#{216}r￿
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are involved in transducing growth-regulatory signals from
the cell membrane to the nucleus. The potential role of this
signaling pathway in the induction ofcellular differentiation,
however, is unclear.
The present studies demonstrate that activation of the
EGR-1 gene during TPA-induced monocytic differentiation
is mediated through serum response or CArG elements. Pre-
vious work has demonstrated that pp901￿ directly phospho-
rylates SRF (28). Since this phosphorylation of SRF enhances
the affinity and rate with which it interacts with the CArG
box (28), we asked whether pp9orsk is activated during
monocytic differentiation. Using both TPA and okadaic
acid, an inhibitor of serine/threonine protein phosphatases
PP-i and PP-2A, we demonstrate that activation of nuclear
pp90￿ is associated with induction of EGR-1 and the
differentiated monocytic phenotype.
Results
Previous work has demonstrated that treatment of human
myeloid leukemia cells is associated with increased EGR-1
mRNA levels (6). Similar findings were obtained in the
present studies with U-937 cells (Fig. 1A). Although the
3.4-kb EGR-1 transcripts were at low to undetectable levels
in untreated U-937 cells, exposure to 32 nsa TPA resulted in
increased EGR-1 expression, which was detectable at 1 h
and maximal at 3-6 h (Fig. 1A). Exposure of U-937 cells to
40 ng/ml okadaic acid was also associated with a transient
induction of EGR-1 expression, which was maximal at 3-6
h (Fig. 1A). These findings were compared with the effects
ofTPA and okadaic acid on a U-937 cell variant, designated
TUR, which was selected for resistance to TPA-induced
growth inhibition and other characteristics, such as adher-
ence, ofthe differentiated monocytic phenotype. In contrast
to the effects of TPA on U-937 cells, induction of EGR-l
expression was attenuated during TPA treatment ofthe TUR
clone (Fig. 1B). However, the finding that TUR cells respond
to okadaic acid with increases in EGR-l mRNA levels
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- 1 8 S Fig. 1. Induction o EGR-1 expres-
sion by okadaic acid and TPA.
U-937 (A) and TUR (B) cells were
treated with 32 n￿ TPA or 40 nWml
okadaic acid (OA) for the indicated
times. Total cellular RNA (20 pg) was
hybridized to the 32P-labeled EGR-1
probe. Hybridization to the actin
probe demonstrated equal loading
of the lanes.
indicated that certain signaling pathways associated with
induction of this gene are intact in the variant (Fig. 1 8).
In order to determine the mechanisms responsible for
TPA-induced EGR-l mRNA levels, we used a construct con-
taming the EGR-1 promoter region (positions -957 to + 248)
ligated to the CAT reporter gene (pEGR-l P1 .2). This region
includes several potential regulatory elements with two Jun/
AP-1 binding sites and six CArG boxes (Fig. 2A). Exposure
of pEGR-1 P1 .2-transfected U-937 cells to TPA was associ-
ated with a 4.5 ± 1.7-fold (mean ± SD of three determi-
nations) increase in CAT activity compared with transfected
cells not exposed to this agent (Fig. 28). In contrast, there
was no detectable induction ofthe minimal pE7O-CAT con-
struct (Fig. 28). Similar studies were performed with pE425
(positions -425 to +65; six CArG boxes without the two
AP-l sites). pE425 was somewhat more responsive to TPA
than pEGR-l P1 .2, with a 7.2 ± 2.1 -fold (mean ± SD of three
determinations) increase in TPA-induced CAT activity com-
pared with that obtained with pE425 transfected, but un-
treated, cells (Fig. 28). Transfection of pE395, which con-
tains the five proximal CArG boxes, also conferred TPA
inducibility, whereas deletion ofthe next CArG box (pE359)
resulted in little if any TPA-induced CAT activity (Fig. 28).
These findings indicated that the region encompassing the
first two CArG elements mediates TPA-induced expression
of the EGR-l gene.
Similar transient expression studies were performed with
TUR cells. However, there was no detectable inducibihity of
the EGR-1 promoter-CAT constructs during TPA treatment of
these cells. For example, percentage conversion with pE425
was 0.16 and 0.19 in control and TPA-induced TUR cells,
respectively. In contrast, these cells responded to okadaic
acid with activation of EGR-1 transcription. Transfection of
the pE425 construct demonstrated okadaic acid responsive-
ness with a 4.4 ± 1 .1 -fold increase in CAT activity, whereas
little inducibihity by okadaic acid was observed with both
pE395 and pE359 (Fig. 3). Other studies with U-937 cells-.500 -250 0 +248
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Fig. 3. Okadaic acid-induced EGR-1 transcription is conferred by the 5’-
most CArG element. TUR cells were transfected with the constructs shown
in Fig. 2A and maintained in medium for 36 h. Okadaic acid (OA( was then
added, and the cells were harvested after 9 h for analysis ofCAT activity. The
percentage conversion of chloramphenicol to the acetylated forms as deter-
mine(I I)y scintittation counting is shown for control (C) and okadaic acid
(OA(-treated cells. The relative fold increase (mean ± SD) in CAT activity for
control versus OA-treated cells was calculated as: pE425 In = 3), 4.4 ± 1.1;
pE395 (n = 3(, 1 .4 ± 0.33; pE359 (n = 3), 0.76 ± 0.11.
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Fit,’. 2. TPA-induced EGR-1 tran-
scription is regulated by CArG ele-
nients. A, u-q37 cells were trans-
fected with the indicated constructs
and maintained in medium for 36 h.
TPA was then added, and the cells
were harvested after 9 h for analysis
ofCAT activity. Hatchedbars, AP-1
sites; solid bars, CArG boxes. B,
conversion of chloramphenicol to
the acetylated tornis is shown for
control (C( and TPA-treated cells
transfected with the indicated con-
structs. Percentage conversion was
determi ned by scintillation count-
ing. The relative fold increase
(mean ￿ SD) in CAT activity for
control versus TPA-treated cells
was calculated as: pEGR-1 P1 .2
(n = 3(, 4.5 ± 1.7; pE7O (n = 2),
1.24 ￿ 0.16; pE425 In = 3), 7.2 ±
2.1; pE395 (n - 3(, 5.7 ± 2.1;
pE359 (n = 3(, 1.31 ± 0.22.
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have demonstrated that the first CArG element linked to the
heterologous herpes simplex virus thymidine kinase mini-
mal promoter and CATgene is able to confer okadaic acid
responsiveness, whereas there was no detectable inducibil-
ity with a similar heterologous promoter construct contain-
ing a mutated CC(A/V)6GG sequence (1 3). Similar findings
were obtained in okadaic acid-treated TUR cells (data not
shown). Taken together, these findings indicated that the first
CArG element mediates okadaic acid-induced expression of
the EGR-l gene in the wild-type U-937 and variant TUR
cells.
One of the early responses to mitogen-induced cellular
growth isthe phosphorylation ofserine/threonine residues in
certain translational components such as the ribosomal 56
protein (29). Although activation of pp70S6K results in the
phosphorylation of 56 (30), it is not known whether other
substrates exist for this kinase. Since previous studies have
demonstrated that TPA activates pp70S6K in quiescent 3T3
cells (31), we used immunoblot analysis to study pp7056K in
lysates from U-937 cells. The results demonstrate little if any
change in pp70S6￿< levels or electrophoretic mobility follow-
ing treatment with TPA (Fig. 4A). Similar findings were ob-
tamed during exposure to okadaic acid (data not shown).
There was also no detectable change in pp7OS6K during
treatment of TUR cells with TPA or okadaic acid (data not
shown). Recent studies have shown that the macrolide ra-
pamycin specifically blocks signaling by pp70S6K (3 1-33).
Consequently, we asked whether rapamycin inhibits events
associated with induction of U-937 cell differentiation. This
agent had no detectable effect on TPA-induced growth arrest
or adherence of U-937 cells (data not shown). Moreover,
rapamycin had little effect on TPA- or okadaic acid-induced
EGR-l expression (Fig. 48). These findings and the absence
of pp7oS6K activation indicated that pp70S6K signaling is not
essential for induction of the EGR-l gene and other char-
acteristics of monocytic differentiation.
Previous studies have demonstrated that pp70S6K and
pp9O#{176}￿ are differentially regulated by a variety of mitogensA.
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Fin. 4. Activation of pp7OSt￿K is not associated with TPA- or okadaic acid-
induced monocytic differentiation. A, U-937 cells were treated with TPA for
the indicated times. Soluble proteins (75 pg( were subjected to electrophoresis
in 7.5/, SDS-polyacrylamide gels and transferred to nitrocellulose paper. The
filters were incubated with an anti￿pp70S￿K antiserum, and reactivity was
visualized by chemiluminescence. Position of the 69 kd molecular weight
marker is shown. B, U-937 cells were treated with TPA or okadaic acid (OA(
for 6 h. Cells were also pretreated with 80 nsa rapamycin (RAP) for 3 h and
then exposed to TPA or OA. Total cellular RNA (20 pg( was hybridized to the
#{176}P-labeled EGR-1 probe. Hybridization to the actin probe demonstrated
equal loading of the lanes.
(1 8, 20, 31 , 34, 35). Consequently, we asked whether TPA-
induced differentiation of U-937 cells is associated with ac-
tivation of pp9orsk. These studies were performed by pun-
fying pp90rsk and then assaying for phosphorylation of 56
peptide. Extracts of U-937 cells treated with TPA were par-
tially purified by Q Sepharose Fast Flow chromatography.
Increases in 56 peptide phosphorylation were detectable at
30 mm of TPA treatment (data not shown). This activity was
further purified by absorption to Mono Q anion exchange
beads and then elution with a linear NaCI gradient. The
TPA-induced pp90rsk activity was detectable in a peak that
eluted with 0.1 3 M NaCI (Fig. 5A). In contrast, there was little
if any 56 peptide phosphorylation when using protein pu-
rified from uninduced U-937 cells (Fig. 5A). Immunoblot
analysis of the Mono Q eluate with the anti-pp90￿￿ anti-
serum revealed a major species at approximately 90 kilo-
daltons in the active fractions (Fig. 58). Similarfindings were
obtained in okadaic acid-treated U-937 cells. Treatment
with okadaic acid was associated with an increase in pp9orsk
activity compared to that in control cells (Fig. 6). In contrast,
assays of ppgorsk activation in TUR cells revealed a different
pattern. Treatment of TUR cells with TPA had no detectable
effect on pp9orsk phosphotransferase activity, whereas phos-
phorylation of 56 peptide was stimulated after adding oka-
daic acid (Fig. 7). These findings and the results obtained
with U-937 cells indicated that pp9orsk activation is asso-
ciated with induction of EGR-l expression and monocytic
differentiation.
Discussion
The present studies have used U-937 myeloid leukemia cells
and a TPA-resistant U-937 variant to study signaling events
associated with induction of monocytic differentiation. The
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Fig. 5. Effects of TPA on pp9Oask activity in U-937 cells. U-937 cells were
treated with TPA for 30 mm. A, the cells were lysed, and the soluble fraction
was applied to a Q Sepharose column. Protein eluting at 0.2 si NaCI was
adjusted to 0.02 M NaCI and then applied to a Mono Q column. Fractions were
assayed for phosphorylation of 56 peptide after elution with a 0.0-0.5 xi NaCI
linear gradient. EL control; #{149}, TPA-treated. B, fractions from the Mono Q
column were subjected to electrophoresis in 7.5% SDS-polyacrylamide gels
and transferred to nitrocellulose filters. The filters were incubated with an
anti-pp90’￿’ antiserum, and reactivity was visualized by a peroxidase detec-
tion system.
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Fig. 6. Effects ofokadaic acid on pp9O’￿’ activity in U-937 cells. U-937 cells
were treated with okadaic acid for 3 h. Soluble proteins (Li,control; 0, OA-
treated) were separated by Q Sepharose and then Mono Q column chroma-
tography. The fractions were assayed for phosphorylation of S6 peptide.
TUR clone was isolated from a single U-937 cell selected for
resistance to the growth-inhibitory effects of 5 flM TPA. This
variant fails to exhibit growth arrest, adherence, or increases
in a-naphthylacetate esterase staining, all characteristics of
the differentiated monocytic phenotype, when exposed to
TPA at concentrations as high as 500 nsi (36). Other work has
demonstrated that monocytic differentiation of U-937 cells
is also associated with increased expression of the EGR-1
gene (6). Similar findings were obtained with additional in-
ducers of U-937 cell differentiation, including okadaic acid,
and during activation of resting human peripheral blood
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monocytes (6, 1 3). More importantly, recent work has dem-
onstrated that EGR-1 expression is required for induction of
monocytic differentiation (1 4). In the present studies, TPA
induced little EGR-1 expression in TUR cells, whereas oka-
daic acid treatment was associated with induction of this
gene. Okadaic acid is an inhibitor of serine/threonine pro-
tein phosphatases (37-39) and in earlier studies was found
to induce monocytic differentiation of U-937 cells (40).
Treatment of TUR cells with okadaic acid was also associ-
ated with growth arrest and the appearance of a differenti-
ated monocytic phenotype (36). These findings indicated
that signaling events associated with induction ofthe EGR-1
gene and monocytic differentiation are regulated at least in
part by serine/threonine protein phosphorylation.
Several serine/threonine protein kinases have been iden-
tified that participate in the regulation of cell growth and
differentiation. TPA activates the serine/threonine-specific
PKC (4), and thus this kinase functions in initial signals that
contribute to monocytic differentiation. However, studies
with the TPA-resistant TUR clone suggest that other events,
potentially downstream of PKC, can be activated by okadaic
acid and thereby induce a monocytic phenotype. Indeed,
characterization of the TUR variant has demonstrated de-
creased levels of PKC isoforms (36). Similar decreases in PKC
expression have been reported for TPA-resistant HL-60
myeloid leukemia cells (41 , 42). The present studies have
therefore focused on two other senine/threonine protein ki-
nases, pp70S6K and pp9O￿￿, that phosphorylate the 40S ri-
bosomal 56 protein. Previous work has shown that
mitogen-induced growth is associated with phosphoryla-
tion of 56 protein (29). TPA-induced mitogenesis of quies-
cent cells is associated with activation of pp7OSbK (31).
Moreover, selective inhibition of pp7OSbK with rapamycin
blocks interleukin 2-induced entry of T-cells into S phase
(32). Of interest, TPA treatment of U-937 cells had no de-
tectable effect on pp7056K. Furthermore, rapamycin, an in-
hibitor of pp7056K, failed to block TPA-induced EGR-1 ex-
pression and appearance of the monocytic phenotype. The
finding that okadaic acid treatment of both U-937 and
TUR cells has no effect on this kinase also supported the
lack of involvement of pp7OS6K in monocytic differentia-
tion. Thus, pp70S6￿( would appear to be activated during
mitogenesis, but not differentiation of certain cell types.
Although pp9orsk also phosphorylates S6 protein, this ki-
nase, in contrast to pp7056K, exhibits phosphotransferase
activity toward a variety of other substrates. For example,
activated pp9O￿ and its homologues phosphorylate MAP2
(31 ), c-fos (27), histone H3 (27), lamin C (43), and glycogen
synthase (44). Previous studies have demonstrated that the
pp9Or￿ signaling cascade transduces growth-regulatory sig-
nals to the nucleus, whereas less is known about the role of
this kinase in the induction of differentiation. The present
results demonstrate that pp90￿’ is also activated during
monocytic differentiation. TPA treatment of U-937 cells, but
not the TUR variant, was associated with activation of
pp9O￿￿ as determined by increased phosphorylation of 56
peptide. Activation ofpp9O￿’ was also found during okadaic
acid-induced differentiation of both U-937 and TUR cells.
Although the mechanisms responsible for this activation of
pp9#{216}rsk in these TPA- and okadaic acid-treated cells have
not been defined in the present studies, previous work has
shown that pp9orsk is activated by MAP kinase (23, 24).
Moreover, MAP kinase and pp9O￿￿ exhibit coordinate tem-
poral regulation and spatial distribution following addition
of growth factors to serum-deprived cells (27). Other studies
have demonstrated that MAP kinase is activated in TPA-
induced U-937 cells(26), and we haveobtained similar find-
ings in okadaic acid-treated U-937 and TUR cells (data not
shown). Stimulation of MAP kinase activity was detectable
at low levels in TPA-treated TUR cells and was less pro-
nounced than that obtained with okadaic acid or during in-
duction of U-937 cells (data not shown). Thus, activation of
MAP kinase may be responsible for stimulation of ppg#{248}rsk
activity during both mitogenesis and induction of monocytic
differentiation.
Certain insights are available regarding the relationship
between activation ofthe MAP kinase/pp90￿’￿ signaling cas-
cade and induction of early response gene expression. MAP
kinase phosphorylates c-Jun and thereby may contribute to
Jun/AP-1 -mediated activation of c-jun gene transcription
(26). pp9O￿az phosphorylates a COOH-terminal serine in
c-Fos which is necessary for transcriptional transrepression
of the c-fos promoter (27, 45). This COOH-terminal region
of c-Fos is also required for down-regulation of EGR-1 gene
transcription after mitogenic stimulation (46). The target for
this repression is the SRE or CArG box (46). pp9Orsk phos-
phorylates SRF in vitro at the same site (serine 103) that is
phosphorylated in vivo after growth factor stimulation (28).
Since SRF also interacts with the SRE (47, 48), and phos-
phorylation at serine 103 enhances the affinity of SRF bind-
ing to the SRE (28), pp9orsk may coordinate the transcription
of genes regulated by this element. Other studies have dem-
onstrated that the SRE interacts with both SRF and p62TcF,
and that phosphorylation of p62TcF by MAP kinase stimu-
lates formation of this ternary complex (49). The present
work demonstrates that TPA-induced EGR-l gene transcrip-
tion in U-937 cells is conferred by the region of the EGR-1
promoter containing the first and second CArG elements. In
contrast, there was no detectable activation of EGR-l
promoter-reporter constructs in TPA-treated TUR cells.
Moreover, as previously demonstrated in okadaic acid-
treated U-937 cells (1 3), the present work shows thatthe first
CArG element confers okadaic acid inducibility of EGR-l
transcription in TUR cells.
The findings thus suggest that activation of the MAP
kinase/pp90￿￿ cascade may contribute to induction of
EGR-l transcription through phosphorylation of serum re-
sponse factor and p62TcF. Direct support for this mechanism
would be provided by increased binding of these factors to
the proximal CArG sites in the EGR-l promoter. However,264 Induction of EGR-1 Gene Transcription
we have been unable thus far to demonstrate a significant
and reproducible shift in electrophoretic mobility patterns
using the proximal CArG box and nuclear proteins from in-
duced U-937 cells. Finally, although MAP kinase/pp90rsk
activation and EGR-l induction have been associated with
mitogenesis, the present findings support the involvement of
these signaling pathways in the differentiation of myeloid
leukemia cells.
Materials and Methods
Cell Culture. U-937 cells (50) and a TPA-unresponsive
U-937 variant, designated TUR (36), were grown in RPMI
1640 medium containing 10% heat-inactivated fetal bovine
serum supplemented with 100 units/mI penicillin, 100 ￿ig/ml
streptomycin, and 2 m￿a i-glutamine. Cells were exposed to
32 nsi TPA (Sigma Chemical Co., St. Louis, MO), 40 ng/ml
okadaic acid (Moana Bioproducts, Honolulu, HI), and 80 nM
rapamycin (Drug Synthesis and Chemistry Branch, National
Cancer Institute, Bethesda, MD).
RNA Isolation and Northern Blot Analysis. Total cellular
RNA was isolated by the guanidine isothiocyanate-cesium
chloride method (51 ). The RNA (20 pig) was analyzed by
electrophoresis in 1% agarose-2.2 M formaldehyde gels and
transferred to nitrocellulose filters. Hybridizations were per-
formed as previously described (6) with the following 32P-
labeled DNA probes: (a) the 0.7-kb non-zinc finger insert of
a murine Egr-1 complementary DNA (1 0); and (b) the 2.0-kb
Pstl insert of a chicken g3-actin gene purified from the pAl
plasmid (52).
Reporter Assays. The pEGR-1P1.2, pE425, pE395,
pE359, and pE7O constructs were prepared as described
(46). The vectors were transfected into cells using the DEAE-
dextran technique (53). Briefly, 2 x 10￿ cells were harvested
and washed with PBS. The cells were resuspended in 1 ml
of 20 m￿ Tris-HCI (pH 7.4) buffer containing 0.5 mg/mI
DEAE-dextran, 8 pg plasmid, 140 mvi NaCI, 5 m￿i KCI, 375
hiM Na2HPO47H2O, 1 mM MgCI2, and 675 ￿M CaCl2. The
cells were incubated at 37#{176}C for 45 mm, washed with media
containing 10% fetal bovine serum, resuspended in com-
plete media, and then incubated at 37#{176}C. Thirty-six h after
transfection, the cells were distributed equally into two ali-
quots; one ahiquot served as a control, and the other was
treated with TPA or okadaic acid. The cells were harvested
after 9 h and lysed by three cycles of freezing and thawing
in 0.25 M Tris-HCI (pH 7.8) and 1 msa phenylmethylsulfonyl
fluoride. Equal amounts of the cell extracts were incubated
with 0.025 pCi [14C]chloramphenicol, 0.1 5 si Tris-HCI (pH
7.8), and 0.4 mM acetyl-CoA for 1 h at 37#{176}C. The enzyme
assay was terminated by addition of ethyl acetate. The or-
ganic layer containing the acetylated [i 4Clchloramphenicol
was separated by thin-layer chromatography using chloro-
form-methanol (95%/5%; v/v). Following autoradiography,
both acetylated and unacetylated forms of [‘4Cjchloram-
phenicol were cut from the plates, and the conversion of
chloramphenicol to the acetylated form was calculated by
measurement of radioactivity in a a-scintillation counter.
Subcellular Fradionation. Cells were washed twice with
ice-cold PBS and lysed in 1 ml of hypotonic lysis buffer (1
mM ethyleneglycol bis(￿-aminoethyl ether)-N,N,N’,N’-
tetraacetic acid, 1 m￿ EDTA, 10 msi ￿3-gIycerophosphate, 1
mM sodium orthovanadate, 2 ms￿ MgCI2, 10 msi KCI, 1 mt￿i
dithiothreitol, 40 pg/mI phenylmethylsulfonyl fluoride, and
10 pg/mI of both leupeptin and aprotinin). The cell suspen-
sion was incubated on ice for 30 mm to allow swelling. After
Dounce homogenization of the cells (20-25 strokes, tight
pestle A), the lysate was loaded onto 1 ml of 1 M sucrose in
lysis buffer and centrifuged at 1,600 X g for 15 mm. The
supernatant above the sucrose gradient was again centri-
fuged at 150,000 X gfor 30 mm. The resulting soluble frac-
tion was adjusted to 0.5% Nonidet P-40, 0.1 % deoxy-
chohate, and 0.1 % Brij 35 and used as the cytosolic fraction.
Immunoblot Analysis. Phosphorylation of pp7OS6K and
pp9O￿k were performed as described (1 8). Proteins were
separated in 7.5% SDS-polyacrylamide gels and transferred
to nitrocellulose paper. The residual binding sites were first
blocked by incubating thefilter in 5% dry milk in PBST (PBS-
0.05% Tween 20) for 1 h at room temperature. The filters
were then incubated with either a rabbit anti￿pp70S6K or a
rabbit anti-pp90￿￿ antiserum for 1 h with shaking. After
washing three times with PBST, the blots were incubated
with anti-rabbit lgG peroxidase conjugate (Sigma). The
antigen-antibody complexes were visualized by chemilu-
minescence (ECL detection system; Amersham, Arlington
Heights, IL).
Partial Purification of pp9O￿ Activity. The cytosolic
fraction was applied to a Q Sepharose Fast Flow column
(1 .0 ml; Pharmacia, Piscataway, NJ). After washing with
buffer A [20 mM Tris-HCI (pH 7.4), 0.5 mr￿i ethyleneglycol
bis(￿3-aminoethyl ether)-N,N,N’,N’-tetraacetic acid, 0.5 mt￿a
EDTA, and 10 mM f3-mercaptoethanohl, proteins were eluted
with 3 ml of 0.2 M NaCI-buffer A, adjusted to 0.02 M NaCI
with buffer A, and applied to a Mono Q column (HR 5/5;
Pharmacia). The column was washed with buffer A. Protein
was eluted with a linear 0.0-0.5 M NaCI-buffer A gradient.
Fractions were assayed for pp9O￿￿ activity by incubation in
the presence of 50 ￿M S6 peptide (RRRLSSLRA), 20 ￿M
[‘y-32P]ATP, 10 m￿ MgCI2, and 0.4 m￿i dithiothreitol. After
incubation for 15 mm at 30#{176}C, 25 p1 ofthe reaction mixture
were loaded onto phosphocellulose discs (GIBCO-BRL,
Grand Island, NY). The discs were washed three times with
1% phosphoric acid and then with water before scintillation
counting.
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